{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:57:56Z","timestamp":1763535476232,"version":"build-2065373602"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clinre.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T21:46:27Z","timestamp":1504561587000},"page":"617-625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Autoimmune hepatitis\u00a0\u2014\u00a0update on clinical management in 2017"],"prefix":"10.1016","volume":"41","author":[{"given":"Timur","family":"Liwinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2017.07.002_bib0005","first-page":"113","article-title":"Blutproteine und Nahrungseiweiss","volume":"9","author":"Leber","year":"1953","journal-title":"Dtsch Z Verdau Stoffwechselkr"},{"key":"10.1016\/j.clinre.2017.07.002_bib0010","first-page":"1323","article-title":"Lupoid hepatitis","volume":"271","author":"Cowling","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2017.07.002_bib0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1749-6632.1965.tb19000.x","article-title":"Autoimmune hepatitis","volume":"124","author":"Mackay","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinre.2017.07.002_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2017.07.002_bib0025","doi-asserted-by":"crossref","first-page":"443e5","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.clinre.2017.07.002_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000440705","article-title":"Worldwide incidence of autoimmune liver disease","volume":"33","author":"Jepsen","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2017.07.002_bib0035","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0040","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/liv.13236","article-title":"Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2017.07.002_bib0050","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0055","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0060","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0070","article-title":"Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda","author":"Sebode","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2017.07.002_bib0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-016-8579-y","article-title":"Challenges in the standardization of autoantibody testing: a comprehensive review","volume":"53","author":"Tozzoli","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0080","doi-asserted-by":"crossref","first-page":"e92267","DOI":"10.1371\/journal.pone.0092267","article-title":"Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen\/liver pancreas in autoimmune hepatitis","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2017.07.002_bib0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MCG.0000000000000805","article-title":"Natural history and treatment outcomes of severe autoimmune hepatitis","volume":"51","author":"Sonthalia","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0090","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2016.267","article-title":"Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria","volume":"30","author":"Balitzer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0095","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2016-204271","article-title":"Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients","author":"Nguyen Canh","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0100","first-page":"477","article-title":"The indications for liver biopsy","volume":"109","author":"Tannapfel","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.clinre.2017.07.002_bib0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000444472","article-title":"Variant syndromes of autoimmune liver diseases: classification, diagnosis and management","volume":"34","author":"Weiler-Normann","year":"2016","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2017.07.002_bib0110","doi-asserted-by":"crossref","first-page":"103e2","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0115","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1111\/hepr.12532","article-title":"Natural history and outcomes in drug-induced autoimmune hepatitis","volume":"46","author":"Yeong","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2017.07.002_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2010.04320.x","article-title":"Review article: drug-induced liver injury in clinical practice","volume":"32","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2017.07.002_bib0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug induced liver injury and its relationship to autoimmune hepatitis","volume":"55","author":"Weiler-Normann","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1751-2980.12479","article-title":"Chinese consensus on the diagnosis and management of autoimmune hepatitis (2015): Chinese Society of Hepatology, Chinese Society of Gastroenterology & Chinese Society of Infectious Diseases","volume":"18","author":"Ma","year":"2017","journal-title":"J Dig Dis"},{"key":"10.1016\/j.clinre.2017.07.002_bib0135","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/hep.23924","article-title":"Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis","volume":"52","author":"Muratori","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"10.1016\/j.clinre.2017.07.002_bib0145","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2017.07.002_bib0155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials","volume":"53","author":"Lamers","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0160","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0165","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/apt.13907","article-title":"Expert clinical management of autoimmune hepatitis in the real world","volume":"45","author":"Liberal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2017.07.002_bib0170","article-title":"Efficacy and limitations of budesonide as a second-line treatment for patients with autoimmune hepatitis","author":"Peiseler","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0175","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review","volume":"52","author":"Wang","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cgh.2015.07.017","article-title":"Features and progression of asymptomatic autoimmune hepatitis in Italy","volume":"14","author":"Muratori","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0190","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.dld.2016.06.018","article-title":"Predictive factors of poor response to therapy in autoimmune hepatitis","volume":"48","author":"Muratori","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2017.07.002_bib0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2015.09.037","article-title":"Efficacy of 6-mercaptopurine as second-line treatment for patients with autoimmune hepatitis and azathioprine intolerance","volume":"14","author":"H\u00fcbener","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0200","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.3748\/wjg.v20.i13.3475","article-title":"Therapeutic drug monitoring in patients with inflammatory bowel disease","volume":"20","author":"Yarur","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jceh.2017.01.115","article-title":"Role of allopurinol in optimizing thiopurine therapy in patients with autoimmune hepatitis: a review","volume":"7","author":"Deswal","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0210","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0215","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy","volume":"24","author":"Sharzehi","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0220","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/00365521.2015.1095351","article-title":"Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on tacrolimus therapy","volume":"51","author":"Than","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.06.001","article-title":"Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis","author":"Efe","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0230","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000456588","article-title":"Can understanding the pathogenesis of autoimmune hepatitis lead to rational therapy?","volume":"35","author":"Lohse","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2017.07.002_bib0235","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0240","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0245","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3109\/00365521.2014.998271","article-title":"Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use","volume":"50","author":"Ytting","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0250","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.28517","article-title":"Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis","volume":"64","author":"Chen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0260","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jhep.2014.05.034","article-title":"Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies","volume":"61","author":"Taubert","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0265","first-page":"7181685","article-title":"Autoimmune hepatitis: progress from global immunosuppression to personalised regulatory T cell therapy","volume":"2016","author":"Than","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0270","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2017.07.002_bib0275","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome","volume":"61","author":"Yeoman","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0280","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2015.04.032","article-title":"The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable","volume":"63","author":"de Martin","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0285","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jhep.2016.03.023","article-title":"Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune hepatitis","volume":"65","author":"Moenne-Loccoz","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0290","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2006.02894.x","article-title":"Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases","volume":"23","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2017.07.002_bib0295","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2017.07.002_bib0300","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12876-014-0191-0","article-title":"New foe treated with old guns\u00a0\u2014\u00a0supportive role of steroids in the treatment of acute severe hepatitis E","volume":"14","author":"Sebode","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0305","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0034-1375959","article-title":"Drug-induced liver injury with autoimmune features","volume":"34","author":"deLemos","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2017.07.002_bib0310","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.04.2011.4069","article-title":"Diagnostic and therapeutic challenges of hepatic sarcoidosis","author":"Mosea","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clinre.2017.07.002_bib0315","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1386-6346(02)00274-7","article-title":"Clinicopathological features of acute-onset autoimmune hepatitis","volume":"25","author":"Okano","year":"2003","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2017.07.002_bib0320","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2016.11.013","article-title":"The management of childhood liver diseases in adulthood","volume":"66","author":"Joshi","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0325","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0330","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.clinre.2017.07.002_bib0335","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000440831","article-title":"Overlap Syndromes","volume":"33","author":"Chazouill\u00e8res","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2017.07.002_bib0340","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0345","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MPG.0000000000001125","article-title":"Clinical characteristics and prognosis in children and adolescents with autoimmune hepatitis and overlap syndrome","volume":"63","author":"Rodrigues","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2017.07.002_bib0350","first-page":"412","article-title":"Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis","volume":"15","author":"Smolka","year":"2016","journal-title":"HBPD INT"},{"key":"10.1016\/j.clinre.2017.07.002_bib0355","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"de Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2017.07.002_bib0360","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0016-5085(84)90186-0","article-title":"Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis","volume":"87","author":"Davis","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0365","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2017.07.002_bib0370","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1007\/s10620-016-4254-7","article-title":"Targeting hepatic fibrosis in autoimmune hepatitis","volume":"61","author":"Montano-Loza","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2017.07.002_bib0375","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis","volume":"65","author":"Hartl","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0380","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","article-title":"Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis","volume":"15","author":"Tansel","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0385","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12936","article-title":"Histologic surveillance after liver transplantation due to autoimmune hepatitis","volume":"31","author":"Puustinen","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.clinre.2017.07.002_bib0390","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.22018","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","author":"Schramm","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2017.07.002_bib0395","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2017.07.002_bib0400","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","article-title":"Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis","volume":"60","author":"Schramm","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.07.002_bib0405","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117301778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117301778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:17Z","timestamp":1761895577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740117301778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2210740117301778"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2017.07.002","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune hepatitis\u00a0\u2014\u00a0update on clinical management in 2017","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}